Therefore, future research should focus on functional studies in order to investigate the mechanisms by which MALAT1 overexpression affects the pathobiology of CLL cells and whether these mechanisms differ between the M-CLL and the U-CLL subtype given their markedly disparate clinical behavior. Here, MALAT1 is linked to B-cell chronic lymphocytic leukemia.